Early-phase 11C-PiB PET in amyloid angiopathy-related symptomatic cerebral hemorrhage: Potential diagnostic value?

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Farid, Karim ^a,b   Hong, Young T ^c   Aigbirhio, Franklin I ^c   Fryer, Tim D ^c   Menon, David K ^c   Warburton, Elizabeth A ^c,d   Baron, Jean Claude ^c,e  

^a HÔTEL DIEU   (France)

^b Martinique University Hospital   (Martinique)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e CENTRE HOSPITALIER SAINTE ANNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PITTSBURGH COMPOUND B; 2-(4'-(METHYLAMINO)PHENYL)-6-HYDROXYBENZOTHIAZOLE; ANILINE DERIVATIVE; RADIOPHARMACEUTICAL AGENT; THIAZOLE DERIVATIVE;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX ATROPHY; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL CORTEX; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; SENSITIVITY AND SPECIFICITY; VASCULAR AMYLOIDOSIS; BRAIN; COMPLICATION; DIAGNOSTIC IMAGING; MIDDLE AGED; SCINTISCANNING;

AGED; ANILINE COMPOUNDS; BRAIN; CEREBRAL AMYLOID ANGIOPATHY; CEREBRAL HEMORRHAGE; FEMALE; HUMANS; MALE; MIDDLE AGED; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; THIAZOLES;

EID: 84947969582     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0139926     Document Type: Article

References (38)

1. Charidimou A, Gang Q, Werring DJ. Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry. 2012; 83: 124-137. doi: 10.1136/jnnp-2011-301308 PMID: 22056963
2. Linn J, Halpin A, Demaerel P, Ruhland J, Giese AD, Dichgans M, et al. Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology 2010; 74: 1346-1350. doi: 10.1212/WNL.0b013e3181dad605 PMID: 20421578
3. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol. 2004; 55: 306-319. PMID: 14991808
4. Price JC, Klunk WE, Lopresti BJ, Lu X, Hoge JA, Ziolko SK, et al. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J Cereb Blood Flow Metab. 2005; 25: 1528-1547. PMID: 15944649
5. Johnson KA, Gregas M, Becker JA, Kinnecom C, Salat DH, Moran EK, et al. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol. 2007; 62: 229-234. PMID: 17683091
6. Greenberg SM, Grabowski T, Gurol ME, Skehan ME, Nandigam RN, Becker JA, et al. Detection of isolated cerebrovascular beta-amyloid with Pittsburgh compound B. Ann Neurol. 2008; 64: 587-591. doi: 10.1002/ana.21528 PMID: 19067370
7. Baron JC, Farid K, Dolan E, Turc G, Marrapu ST, O'Brien E, et al. Diagnostic utility of amyloid PET in cerebral amyloid angiopathy-related symptomatic intracerebral hemorrhage. J Cereb Blood Flow Metab. 2014; 34: 753-758. doi: 10.1038/jcbfm.2014.43 PMID: 24619277
8. Mintun MA, Larossa GN, Sheline YI, Dence CS, Lee SY, Mach RH, et al. [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology. 2006; 67: 446-452. PMID: 16894106
9. Chételat G, La Joie R, Villain N, Perrotin A, de La Sayette V, Eustache F, et al. Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease. NeuroImage: Clinical 2013; 2: 10.
10. Forsberg A, Engler H, Blomquist G, Langstrom B, Nordberg A. The use of PIB-PET as a dual pathological and functional biomarker in AD. Biochim Biophys Acta. 2012; 1822: 380-385. doi: 10.1016/j.bbadis.2011.11.006 PMID: 22115832
11. Rostomian AH, Madison C, Rabinovici GD, Jagust WJ. Early 11C-PIB frames and 18F-FDG PET measures are comparable: a study validated in a cohort of AD and FTLD patients. J Nucl Med. 2011; 52: 173-179. doi: 10.2967/jnumed.110.082057 PMID: 21233181
12. Rocher AB, Chapon F, Blaizot X, Baron JC, Chavoix C. Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons. Neuroimage. 2003; 20: 1894-1898. PMID: 14642499
13. Chung YA, O JH, Kim JY, Kim KJ, Ahn KJ. Hypoperfusion and ischemia in cerebral amyloid angiopathy documented by 99mTc-ECD brain perfusion SPECT. J Nucl Med. 2009; 50: 1969-1974. doi: 10.2967/jnumed.109.062315 PMID: 19910418
14. Koeppe RA, Gilman S, Joshi A, Liu S, Little R, Junck L, et al. 11C-DTBZ and 18F-FDG PET measures in differentiating dementias. J Nucl Med. 2005; 46: 936-944. PMID: 15937303
15. Hsiao IT, Huang CC, Hsieh CJ, Hsu WC, Wey SP, Yen TC, et al. Correlation of early-phase 18F-florbetapir (AV-45/Amyvid) PET images to FDG images: preliminary studies. Eur J Nucl Med Mol Imaging. 2012; 39: 613-620. doi: 10.1007/s00259-011-2051-2 PMID: 22270508
16. Mosconi L, Andrews RD, Matthews DC. Comparing brain amyloid deposition, glucose metabolism, and atrophy in mild cognitive impairment with and without a family history of dementia. J Alzheimers Dis. 2013; 35: 509-524. doi: 10.3233/JAD-121867 PMID: 23478305
17. Protas HD, Chen K, Langbaum JB, Fleisher AS, Alexander GE, Lee W, et al. Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease. JAMA Neurol. 2013; 70: 320-325. PMID: 23599929
18. Desgranges B, Baron JC, de la Sayette V, Petit-Taboue MC, Benali K, Landeau B, et al. The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization. Brain. 1998; 121 (Pt 4): 611-631. PMID: 9577389
19. Marcus C, Mena E, Subramaniam RM. Brain PET in the diagnosis of Alzheimer's disease. Clin Nucl Med. 2014; 39: e413-422; quiz e423-416. doi: 10.1097/RLU.0000000000000547 PMID: 25199063
20. Masuda J, Tanaka K, Ueda K, Omae T. Autopsy study of incidence and distribution of cerebral amyloid angiopathy in Hisayama, Japan. Stroke. 1988; 19: 205-210. PMID: 3344537
21. Vinters HV, Gilbert JJ. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke. 2012; 14: 924-928.
22. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984; 34: 939-944. PMID: 6610841
23. Avants BB, Epstein CL, Grossman M, Gee JC. Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain. Med Image Anal. 2008; 12: 26-41. PMID: 17659998
24. Laymon CM, Rosario B.L., Redfield A., Berginc M., Klunk W.E., Mathis C.A., et al. Comparative evaluation of template-based region sampling for PiB PET data analysis. NeuroImage. 2010; 51: S219.
25. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002; 15: 273-289. PMID: 11771995
26. Meltzer CC, Leal JP, Mayberg HS, Wagner HN Jr, Frost JJ. Correction of PET data for partial volume effects in human cerebral cortex by MR imaging. J Comput Assist Tomogr. 1990; 14: 561-570. PMID: 2370355
27. Mevel K, Desgranges B, Baron JC, Landeau B, De la Sayette V, Viader F, et al. Detecting hippocampal hypometabolism in Mild Cognitive Impairment using automatic voxel-based approaches. Neuroimage. 2007; 37: 18-25. PMID: 17566762
28. Iwasaki Y, Mori K, Ito M, Deguchi A, Shiraishi T, Mimuro M, et al. An autopsy case of senile dementia suspected to be influenced by cerebral amyloid angiopathy with multiple cortical microinfarcts]. Rinsho Shinkeigaku. 2010; 50: 651-655. PMID: 20960931
29. Tian J, Shi J, Mann DM (2004) Cerebral amyloid angiopathy and dementia. Panminerva Med 46: 253-264. PMID: 15876981
30. Iglesias S, Marchal G, Viader F, Baron JC. Delayed intrahemispheric remote hypometabolism. Correlations with early recovery after stroke. Cerebrovasc Dis. 2000; 10: 391-402. PMID: 10971026
31. Carrera E, Tononi G Diaschisis: past, present, future. Brain. 2014; 137: 2408-2422. doi: 10.1093/brain/awu101 PMID: 24871646
32. Feeney DM, Baron JC. Diaschisis. Stroke. 1986; 17: 817-830. PMID: 3532434
33. Lewis DH, Toney LK, Baron JC. Nuclear medicine in cerebrovascular disease. Semin Nucl Med. 2012; 42: 387-405. doi: 10.1053/j.semnuclmed.2012.06.002 PMID: 23026361
34. Lowe VJ, Weigand SD, Senjem ML, Vemuri P, Jordan L, Kantarci K, et al. Association of hypometabolism and amyloid levels in aging, normal subjects. Neurology. 2014; 82: 1959-1967. doi: 10.1212/WNL.0000000000000467 PMID: 24793183
35. Dumas A, Dierksen GA, Gurol ME, Halpin A, Martinez-Ramirez S, Schwab K, et al. Functional magnetic resonance imaging detection of vascular reactivity in cerebral amyloid angiopathy. Ann Neurol. 2012; 72: 76-81. doi: 10.1002/ana.23566 PMID: 22829269
36. Catafau AM, Bullich S. Amyloid PET imaging: applications beyond Alzheimer's disease. Clin Transl Imaging. 2015; 3: 39-55. PMID: 25741489
37. Meltzer CC, Kinahan PE, Greer PJ, Nichols TE, Comtat C, Cantwell MN, et al. Comparative evaluation of MR-based partial-volume correction schemes for PET. J Nucl Med. 1999; 40: 2053-2065. PMID: 10616886
38. Quarantelli M, Berkouk K, Prinster A, Landeau B, Svarer C, Balkay L, et al. Integrated software for the analysis of brain PET/SPECT studies with partial-volume-effect correction. J Nucl Med. 2004; 45: 192-201. PMID: 14960635